Alkermes
E148148
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Alkermes canonical | 1 |
| Alkermes Pharma Ireland Limited | 1 |
Statements (42)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
public company ⓘ |
| businessModel |
partnership-based drug development
ⓘ
research and development of proprietary medicines ⓘ |
| chairman | Richard Pops ⓘ |
| chiefExecutiveOfficer | Richard Pops ⓘ |
| collaboratesWith | major pharmaceutical companies ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| develops |
biologic therapies
ⓘ
small-molecule drugs ⓘ |
| focusesOn |
central nervous system disorders
ⓘ
serious chronic diseases ⓘ |
| foundedBy |
Michael Wall
ⓘ
Richard Pops ⓘ |
| hasManufacturingFacility |
Athlone
ⓘ
surface form:
Athlone, Ireland
Wilmington, Ohio ⓘ |
| hasOperationalHeadquarters | Waltham, Massachusetts NERFINISHED ⓘ |
| hasSubsidiary |
Alkermes
self-linksurface differs
ⓘ
surface form:
Alkermes Pharma Ireland Limited
|
| headquartersCountry | Ireland ⓘ |
| headquartersLocation | Dublin ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| listedOn |
Nasdaq Global Select Market
ⓘ
surface form:
NASDAQ Global Select Market
|
| product |
Aristada
ⓘ
Aristada ⓘ
surface form:
Aristada Initio
Vivitrol ⓘ |
| regionServed | global ⓘ |
| regulatoryEnvironment |
EMA-regulated
ⓘ
FDA-regulated ⓘ |
| researchFocus |
immuno-oncology
ⓘ
neuroscience ⓘ |
| specializesIn |
drug delivery technologies
ⓘ
long-acting injectable formulations ⓘ |
| stockExchange | NASDAQ ⓘ |
| targetPatientGroup |
patients with addiction disorders
ⓘ
patients with psychiatric disorders ⓘ |
| therapeuticArea |
alcohol dependence
ⓘ
bipolar disorder ⓘ major depressive disorder ⓘ opioid dependence ⓘ schizophrenia ⓘ |
| tickerSymbol | ALKS ⓘ |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Alkermes Pharma Ireland Limited